Choksi Laboratories Ltd

Regulatory update

• US FDA inspected Indore central laboratory Aug 17–20, 2026 and issued four observations; company will respond.

Quarter ended 30 June 2026 results

• Unaudited standalone results approved by Audit Committee and Board.
• Independent auditor Prateek Jain & Co. reviewed results; no material misstatement found.
• Review complied with Ind AS 34 and Listing Regulations.
• Approval date: 13 August 2026.

Financial results

• Unaudited quarterly results for quarter ended 30 June 2026 approved with Limited Review Report.
• XBRL filing of unaudited results to be submitted within 24 hours; results uploaded on company and BSE websites.

AGM planning & governance

• 33rd AGM approved; date fixed 18 September 2026 via VC/OAVM.
• Register of Members and share transfer books closed 12–18 September 2026.
• Cut-off date and remote e-voting period finalized.
• Board's Report, Corporate Governance Report, and MD&A for FY ended 31 Mar 2026 approved.
• Notice of 33rd AGM issued; AGM date 18 September 2026 via VC/OAVM.

Appointments & internal controls

• Re-appointed Himika Choksi as Whole Time Director for five years from 01 Apr 2027, subject to approval.
• Re-appointed Internal Auditor M/s Tanmay V. Rajurkar & Co. for FY 2026-27.
• Scrutinizer appointed: CS Surabhi Agrawal for AGM e-voting.
• Registrar & Share Transfer Agent changed to Ankit Consultancy Private Limited.

Audit remarks

• Independent auditor’s review report: no material misstatement detected.

Meeting Details

• Date: 13 August 2026; Time: 2:30 PM; Location: Registered Office, Indore.

Key Agenda Items

• Consider and approve unaudited quarterly results for the quarter ended 30 June 2026.
• Consider appointment of Internal Auditor for FY 2026-27.
• Consider matters relating to the ensuing Annual General Meeting.

Other Notes

• Trading window closed from 01 July 2026; opens 48 hours after results declaration.

Dematerialisation and ownership updates

• Dematerialisation requests were processed and confirmed to depositories; securities listed on stock exchanges.
• Physical certificates were mutilated and cancelled after verification; ownership updated in records within prescribed timelines.

Meeting Details

• Board meeting scheduled for 25 May 2026 at 2:30 PM.
• Location: registered office, Survey No. 9/1, Near Tulsiyana Industrial Park, Kumerdi, Indore, 453555, Madhya Pradesh.

Key Agenda Items

• Approve standalone audited financial results for Q4 and year ended 31 March 2026.

Other Notes

• Trading window opens 48 hours after declaration of audited results for quarter and year ended 31 March 2026.